Generic drug: levoleucovorin
Brand name: Fusilev
What is Fusilev (levoleucovorin), and how does it work?
Fusilev (levoleucovorin) is a derivative of folic acid indicated for the treatment of metastatic colorectal cancer and bone cancer (after methotrexate therapy).
What are the side effects of Fusilev?
Common side effects of Fusilev include:
- nausea
- vomiting
- diarrhea
- stomach pain
- upset stomach
- numbness or tingling
- loss of appetite
- unusual or unpleasant taste in your mouth
- weakness
- tired feeling
- hair loss, or
- mild skin rash.
Seizures and fainting, though rare, have been reported in patients taking Fusilev.
What is the dosage for Fusilev?
Important Use Information
- Fusilev is indicated for intravenous administration only. Do not administer intrathecally.
Co-Administration Of Fusilev With Other Agents
- Due to the risk of precipitation, do not co-administer Fusilev with other agents in the same admixture.
Recommended Dosage For Rescue After High-Dose Methotrexate Therapy
- The recommended dosage for Fusilev is based on a methotrexate dose of 12 grams/m2 administered by intravenous infusion over 4 hours. Twenty-four hours after starting the methotrexate infusion, initiate Fusilev at a dose of 7.5 mg (approximately 5 mg/m2) as an intravenous infusion every 6 hours.
- Monitor serum creatinine and methotrexate levels at least once daily. Continue Fusilev administration, hydration, and urinary alkalinization (pH of 7 or greater) until the methotrexate level is below 5 x 10-8 M (0.05 micromolar). Adjust the Fusilev dose or extend the duration as recommended in Table 1.
Table 1 Recommended Dosage for Fusilev based on Serum Methotrexate and Creatinine Levels
Clinical Situation | Laboratory Findings | Recommendation |
Normal Methotrexate Elimination | Serum methotrexate level approximately 10 micromolar at 24 hours after administration, 1 micromolar at 48 hours, and less than 0.2 micromolar at 72 hours | Administer 7.5 mg by intravenous infusion every 6 hours for 60 hours (10 doses starting at 24 hours after start of methotrexate infusion). |
Delayed Late Methotrexate Elimination | Serum methotrexate level remaining above 0.2 micromolar at 72 hours, and more than 0.05 micromolar at 96 hours after administration. | Continue 7.5 mg by intravenous infusion every 6 hours until methotrexate level is less than 0.05 micromolar. |
Delayed Early Methotrexate Elimination and/or Evidence of Acute Renal Injury* | Serum methotrexate level of 50 micromolar or more at 24 hours, or 5 micromolar or more at 48 hours after administration OR 100% or greater increase in serum creatinine level at 24 hours after methotrexate administration (e.g., an increase from 0.5 mg/dL to a level of 1 mg/dL or more). | Administer 75 mg by intravenous infusion every 3 hours until methotrexate level is less than 1 micromolar; then 7.5 mg by intravenous infusion every 3 hours until methotrexate level is less than 0.05 micromolar. |
* These patients are likely to develop reversible renal failure. In addition to appropriate Fusilev therapy, continue hydration and urinary alkalinization and monitor fluid and electrolyte status, until the serum methotrexate level has fallen to below 0.05 micromolar and the renal failure has resolved. |
Impaired Methotrexate Elimination Or Renal Impairment
- Decreased methotrexate elimination or renal impairment which are clinically important but less severe than the abnormalities described in Table 1 can occur following methotrexate administration.
- If toxicity associated with methotrexate is observed, in subsequent courses extend Fusilev rescue for an additional 24 hours (total of 14 doses over 84 hours).
Third-Space Fluid Collection And Other Causes Of Delayed Methotrexate Elimination
- Accumulation in a third space fluid collection (i.e., ascites, pleural effusion), renal insufficiency, or inadequate hydration can delay methotrexate elimination.
- Under such circumstances, higher doses of Fusilev or prolonged administration may be indicated.
Recommended Dosage For Overdosage Of Folic Acid Antagonists Or Impaired Methotrexate Elimination
Start Fusilev as soon as possible after an overdosage of methotrexate or within 24 hours of methotrexate administration when methotrexate elimination is impaired. As the time interval between methotrexate administration and Fusilev increases, the effectiveness of Fusilev to diminish methotrexate toxicity may decrease. Administer Fusilev 7.5 mg (approximately 5 mg/m2 ) by intravenous infusion every 6 hours until the serum methotrexate level is less than 5 x 10-8 M (0.05 micromolar).
Monitor serum creatinine and methotrexate levels at least every 24 hours. Increase the dosage of Fusilev to 50 mg/m2 intravenously every 3 hours and continue Fusilev at this dosage until the methotrexate level is less than 5 x 10-8 M for the following:
- if serum creatinine at 24-hours increases 50% or more compared to baseline
- if the methotrexate level at 24-hours is greater than 5 x 10-6 M
- if the methotrexate level at 48-hours is greater than 9 x 10-7 M,
Continue concomitant hydration (3 L per day) and urinary alkalinization with sodium bicarbonate. Adjust the sodium bicarbonate dose to maintain urine pH at 7 or greater.
Dosage In Combination With Fluorouracil For Metastatic Colorectal Cancer
The following regimens have been used for the treatment of colorectal cancer:
- Fusilev 100 mg/m2 by intravenous injection over a minimum of 3 minutes, followed by fluorouracil at 370 mg/m2 by intravenous injection, once daily for 5 consecutive days.
- Fusilev 10 mg/m2 by intravenous injection, followed by fluorouracil 425 mg/m2 by intravenous injection, once daily for 5 consecutive days.
Administer fluorouracil and Fusilev separately to avoid the formation of a precipitate.
This five-day course may be repeated every 4 weeks for 2 courses, then every 4 to 5 weeks, if the patient has recovered from the toxicity from the prior course. Do not adjust Fusilev dosage for toxicity.
Refer to fluorouracil prescribing information for information on fluorouracil dosage and dosage modifications for adverse reactions.
Preparation For Administration
Fusilev For Injection
- Prior to intravenous injection, reconstitute the 50 mg vial of Fusilev for Injection with 5.3 mL of 0.9% Sodium Chloride Injection, USP to yield a levoleucovorin concentration of 10 mg per mL. Reconstitution with Sodium Chloride solutions with preservatives (e.g. benzyl alcohol) has not been studied. The use of solutions other than 0.9% Sodium Chloride Injection, USP is not recommended.
- The reconstituted 10 mg per mL levoleucovorin contains no preservative. Observe strict aseptic technique during reconstitution of the drug product. Discard unused portion.
- Saline reconstituted levoleucovorin solutions may be further diluted, immediately, to concentrations of 0.5 mg/mL to 5 mg/mL in 0.9% Sodium Chloride Injection, USP or 5% Dextrose Injection, USP. Do not store the reconstituted product or reconstituted product diluted using 0.9% Sodium Chloride Injection, USP for more than 12 hours at room temperature. Do not store reconstituted product diluted using 5% Dextrose Injection, USP for more than 4 hours at room temperature.
- Visually inspect the reconstituted solution for particulate matter and discoloration prior to administration. Do not use if cloudiness or precipitate is observed.
- Do not intravenously inject more than 16 mL of reconstituted solutions (160 mg of levoleucovorin) per minute, because of the calcium content of the levoleucovorin solution.
Fusilev Injection
- Levoleucovorin contains no preservative. Observe strict aseptic technique during reconstitution of the drug product. Discard unused portion.
- Levoleucovorin solutions may be further diluted to concentrations of 0.5 mg/mL in 0.9% Sodium Chloride Injection, USP or 5% Dextrose Injection, USP. Do not store the product diluted using 0.9% Sodium Chloride Injection, USP or 5% Dextrose Injection, USP for more than 4 hours at room temperature.
- Visually inspect the diluted solution for particulate matter and discoloration prior to administration. Do not use if cloudiness or precipitate is observed.
- Inject no more than 16 mL of Fusilev Injection (160 mg of levoleucovorin) intravenously per minute, because of the calcium content of the levoleucovorin solution.

SLIDESHOW
Skin Cancer Symptoms, Types, Images See SlideshowWhat drugs interact with Fusilev?
Effects Of Leucovorin Products On Other Drugs
Antiepileptic Drugs
- Folic acid in large amounts may counteract the antiepileptic effect of phenobarbital, phenytoin and primidone and increase the frequency of seizures in susceptible children.
- It is not known whether folinic acid has the same effects; however, both folic and folinic acids share some common metabolic pathways. Monitor patients taking folinic acid in combination with antiepileptic drugs.
Fluorouracil
- Leucovorin products increase the toxicity of fluorouracil. Do not initiate or continue therapy with Fusilev and fluorouracil in patients with symptoms of gastrointestinal toxicity until those symptoms have resolved.
- Monitor patients with diarrhea until the diarrhea has resolved, as rapid deterioration leading to death can occur.
Trimethoprim-Sulfamethoxazole
- The concomitant use of d,l-leucovorin with trimethoprim-sulfamethoxazole for the acute treatment of Pneumocystis jiroveci pneumonia in patients with HIV infection was associated with increased rates of treatment failure and morbidity in a placebo-controlled study.
Is Fusilev safe to use while pregnant or breastfeeding?
- There are limited data with Fusilev use in pregnant women. Levoleucovorin is administered in combination with methotrexate or fluorouracil, which can cause embryo-fetal harm.
- Refer to methotrexate and fluorouracil prescribing information for additional information.
- There are no data on the presence of levoleucovorin in human milk or its effects on the breastfed infant or on milk production.
- Levoleucovorin is administered in combination with methotrexate or fluorouracil.
- Refer to methotrexate and fluorouracil prescribing information for additional information.
Latest Cancer News
Daily Health News
Trending on MedicineNet
Summary
Fusilev (levoleucovorin) is a derivative of folic acid indicated for the treatment of metastatic colorectal cancer and bone cancer (after methotrexate therapy). Common side effects of Fusilev include nausea, vomiting, diarrhea, stomach pain, upset stomach, numbness or tingling, loss of appetite, unusual or unpleasant taste in your mouth, weakness, tired feeling, hair loss, or mild skin rash.
Multimedia: Slideshows, Images & Quizzes
-
Understanding Cancer: Metastasis, Stages of Cancer, and More
Learn the basics about cancer including types, causes, how it spreads, symptoms and signs, stages and treatment options. Read...
-
Colorectal Cancer: Symptoms, Signs, Screening, Stages
Colorectal cancer (colon cancer) is the cause of many cancer deaths. Learn about the warning signs, symptoms, screening process,...
-
Signs of Cancer in Women: Symptoms You Can't Ignore
Cancer symptoms can surprise women if they don't know what to watch out for. 15 cancer symptoms women ignore such as weight loss,...
-
Cancer: Guide to Leukemia
Learn about the common types and stages of leukemia, who gets it, symptoms, tests, treatments, and more. People with blood cancer...
-
Colon Cancer: How Your Diet Can Affect Colorectal Cancer
Diet, including nutrient, antioxidant, and vitamin intake, affects colon cancer risk. Certain dietary factors either decrease or...
-
Cancer-Fighting Foods: Resveratrol, Green Tea, and More
Experts have praised certain foods for their ability to reduce cancer risks. Learn which foods and eating strategies may help...
-
Signs of Cancer in Men: Could it Be Cancer?
See pictures of which 15 cancer symptoms men ignore such as skin changes, difficulty swallowing, rapid weight loss, a breast...
-
Cancer: Visual Guide to Thyroid Cancer
Find out the symptoms of thyroid cancer, and learn how to treat it after you get a diagnosis.
-
Top 10 Cancers Quiz
Take this quiz to learn the causes of cancer. Get the facts about the causes, symptoms, and treatments for the world's most...
-
Cancer: How to Lower and Cut Your Risk of Cancer
About a third of all cases of cancer can be prevented. Find out how to lower your chances of getting it.
-
Picture of Colon Cancer
Most, if not all, of these cancers develop from colonic polyps. Removal of these precancerous polyps can prevent colon cancer....
-
Cancer Guide to Eye Cancers
Find out more from WebMD about the early signs of these types of cancer and how they’re diagnosed and treated.
-
Cancer: Does This Cause Cancer?
Everything gives you cancer, right? Not really. WebMD's slide show tells you about the research into cancer and cell phones,...
-
Cancer: Guide to Testicular Cancer
Testicular cancer is one of the most common cancers for men ages 15 to 35, but it's very treatable. WebMD explains when to see...
-
Cancer: Cancer 'Remedies' That Don't Work
You may have read about an all-natural cure for cancer. While many therapies are helpful, some aren't worth your time or money....
Related Disease Conditions
-
Colon Polyps: Symptoms, Causes, Cancer Risk, Treatment, and Prevention
Colon polyps are common growths on the inner lining of the colon. Colon polyps may become cancerous. There are several different types of colon polyps, and the chance of the polyp becoming cancerous depends on the type, size, and histology. Blood in the stool or rectal bleeding are the most common symptoms of colon polyps. Treatment for colon polyps depend on the type, size, and histology.
-
Colon Cancer
Colon cancer (bowel cancer) is a malignancy that arises from the inner lining of the colon. Most, if not all, of these cancers develop from colonic polyps. Removal of these precancerous polyps can prevent colon cancer.
-
What Does Colon Cancer Poop Look Like?
Black, bright red, and pencil-thin stools are red flags for cancer of the bowel.
-
Bone Cancer
Bone cancer is a rare type of cancer that occurs in cells that make up the bones. Primary bone cancer that arises in bone cells is different than metastatic bone cancer, which is cancer that arises in another part of the body and then spreads to the bones. Hereditary and environmental factors likely contribute to the risk of bone cancer. Signs and symptoms of bone cancer may include pain, the presence of a mass or lump, and bone fractures. There are different types of bone cancer (osteosarcoma, chondrosarcoma, Ewing's sarcoma, pleomorphic sarcoma, fibrosarcoma). Treatment for bone cancer may include surgical removal of the tumor, chemotherapy, radiation, and/or a stem cell transplant. The prognosis for bone cancer depends on the type of cancer and the extent of spread.
-
Early Warning Signs and Stages of Colon Cancer
Colon cancer or colorectal cancer, is a type of cancer that begins in the cells lining the large intestine (colon). In the early stages of colon cancer, warning signs and symptoms usually don’t occur. Colon cancer usually does not have any signs or symptoms. As the cancer grows and expands it may begin to produce signs and symptoms, for example, diarrhea, constipation, blood in the stool, and narrow or pencil-thin stools.There are four stages of colon cancer; however, The term Stage 0 is sometimes used for a very early cancer that only affects the lining of the intestine. The other stages of colon cancer are stage 1, 2, 3, and 4.
-
Cancer Risk Factors
Though it's difficult to say why some people develop cancer while others don't, research shows that certain risk factors increase a person's odds of developing cancer. These risk factors include growing older, family history of cancer, diet, alcohol and tobacco use, and exposure to sunlight, ionizing radiation, certain chemicals, and some viruses and bacteria.
-
Bone Cancer
Second Source article from Government
-
Which Cancer Is the Most Painful?
Cancer spreading to the bone is the most painful type of cancer. Pain can be caused by a tumor pressing on the nerves around the bone. As the tumor size increases, it can release chemicals that irritate the area around the tumor.
-
Anal Cancer
Anal cancer, cancer located at the end of the large intestine, has symptoms that include anal or rectal bleeding, anal pain or pressure, anal discharge or itching, a change in bowel movements, and/or a lump in the anal region. Treatment for anal cancer may involve radiation, chemotherapy, or surgery and depends upon the stage of the cancer, its location, whether cancer is eradicated after the first treatment, and whether the patient has HIV.Anal cancer is usually curable when found localized. Early detection remains the key to long-term survival as it is in many forms of cancer.
-
What Type of Cancer Makes You Very Tired?
Extreme and recurrent tiredness is one of the common symptoms of most types of cancers. Tiredness is usually considered a warning sign of cancer progressing. Tiredness related to cancers usually does not get better with adequate rest or sleep.
-
Guide for COVID-19 Vaccine for Cancer Patients
The authorities have jointly agreed that patients on active cancer treatment are at a higher risk of COVID-19 infection and complications. Hence, there is a necessity to prioritize patients with cancer for the COVID-19 vaccine.
-
Is Cancer Contagious?
Cancer is an abnormal growth of cells. A variety of parasites and viruses have been linked to various cancers. Cancer may metastasize, spreading from its original location to other organs. If you have cancer, you should seek medical care immediately if you experience high fever, shortness of breath, intense headaches, vomiting blood or passing blood rectally, chest pain or moderate to severe weakness, passing out (fainting), mental status changes, or seizures.
-
Which Is the Deadliest Cancer?
Lung cancer is considered to be the most deadly cancer. More people die from lung cancer each year than from breast, colorectal and prostate cancer combined.
-
Early Signs of Colon Cancer
Colon or colorectal cancer may not cause any symptoms during the early stages of the disease. A person may have polyps or colon cancer but may not have any symptoms till the late stages of the disease.
-
Where Does Bone Cancer Usually Start?
Bone cancer occurs when there is an abnormal multiplication of the bone cells. It can arise from any bone in the body. The most commonly affected bones are the pelvis (hip bone) and long bones in the arms and legs such as the humerus and femur bone. Bone cancer is rare.
-
Cancer Fatigue
Cancer fatigue is a lack of energy that is caused by cancer or cancer treatment, including chemotherapy, radiation, biological therapy, or bone marrow transplantation. Strategies to combat cancer fatigue include scheduling rest, pacing oneself, planning ahead and prioritizing work and activities, eating the right foods, exercising, and practicing proper body mechanics.
-
Cancer Prevention
Certain behavioral, lifestyle, and environmental factors contribute to cancer. Cancer prevention involves modifying these factors to decrease cancer risk. Tobacco use, alcohol consumption, physical inactivity, inadequate fruit and vegetable intake, and obesity increase the risk of certain cancers. Vaccines, genetic testing, and cancer screening also play a role in cancer prevention.
-
What Are the 15 Common Signs of Cancer?
The term cancer is given to a group of diseases characterized by the uncontrolled growth of abnormal cells in the body. Some of the common signs of cancer include unintended weight loss, fatigue, bleeding, presence of a mass, persistent cough, abdominal pain and other signs.
-
Colon Cancer Prevention
Colorectal cancer is both curable and preventable if it is detected early and completely removed before the cancerous cells metastasize to other parts of the body. Colonoscopy and flexible sigmoidoscopy (along with digital rectal examination and stool occult blood testing) are both effective at preventing colo-rectal cancers and detecting early colo-rectal cancers.
-
What Is the BRCA Gene?
BRCA genes (BRCA 1 and 2, when normal, repair damaged DNA) are among the genetic mutations linked to breast cancer, ovarian cancer, and other cancers when mutated. Every woman with a BRCA mutation is at high risk for breast cancer, irrespective of whether she has a family history of breast cancer or not. By age 80, a woman with a BRCA mutation has about an 80% chance of developing breast cancer. BRCA1 and BRCA2 gene mutations also increase the risk of ovarian cancer, by 54% and 23%, respectively.
-
Cancer Pain
Cancer pain results from the tumor pressing on nerves or invading bones or organs. Cancer treatments like chemotherapy, radiation, or surgery can also cause pain. Over-the-counter pain relievers, prescription medications, radiation, biofeedback, and relaxation techniques are just some treatments for cancer pain.
-
Is Colonoscopy Painful? What to Expect?
Colonoscopy is a medical procedure to examine the inside of the large bowel (colon). It is done with the help of a long, thin, and flexible tube-like instrument that carries a camera and a light source at one end (colonoscope).
-
How Can We Prevent Cancer?
Cancer is a medical condition in which cells grow out of control and crowd out the normal cells. This makes it difficult for the body to work the way it should. Cancer can start at any place in the body. There are many types of cancer. It’s not just one disease. Cancer can start in the lungs, breast, colon, or blood.
Treatment & Diagnosis
- Colon Cancer
- Anal Cancer
- Bone Cancer
- Gallbladder Cancer
- Bile Duct Cancer (Cholangiocarcinoma)
- Small Intestine Cancer
- Cancer Survival and Attitude with Hamilton Jordan
- Cancer Treatment: Writing to Heal with Margie Davis
- Cancer: Childhood Cancer Survivors
- Cancer: Confronting Cancer with Humor
- Colon Cancer Update: James Church, MD
- Colon Cancer Update
- Cancer: Living Well Despite with Win Boerckel
- Cancer Research: Going the Distance
- Colon Cancer Update with The Cleveland Clinic
- Colorectal Cancer Issues: An Update with Doctors
- Cancer Pain Management with Ann Reiner
- Cancer: The Importance of Joining a Cancer Support Group with Selma Schimmel
- Cancer Patients Need Proper Diet and Exercise
- Cancer: Journaling to Save Your Life
- Cancer: Emotional Aftershocks: When Cancer Comes Back 10/30/02
- Cancers: Children's Cancers
- Cancer FAQs
- Stage IV Colon Cancer That Has Spread to the Liver
- Colonoscopy With No Sedation
- Colon Cancer Prevention And Fiber?
- Cancer Care in the Elderly
- Colon Cancer and Polyp Screening Guidelines
- Colon Cancer Silences Howard Keel
- Colon Cancer, The Genetic Factor
- Treatment of Anal Cancer
- How Long Do You Live After Being Diagnosed with Colon Cancer?
- What Are the Early Signs of Colon Cancer?
- Can virtual colonoscopy replace actual colonoscopy
- What Is the Best Way to Prevent Colon Cancer?
- What Is the Survival Rate for Colon Cancer?
- Does HIV Cause Colorectal Cancer?
- Avoid Red Jell-O Before a Colonoscopy
- How Does Colon Cancer Affect a Person's Body?
- How Often Should I Have a Colonoscopy with Celiac?
- How Soon Should I Have a Followup Colonoscopy?
- Early Bone Cancer Symptoms
- 10 Cancer Symptoms That Men Ignore
Medications & Supplements
Prevention & Wellness
Health Solutions From Our Sponsors

Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.